Orders and sales declined year-over-year, but the order book grew and VerVent integration contributed positively. Management expects improved H2 performance, maintaining full-year sales and EBITDA margin guidance, with cost measures and new product launches supporting recovery.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.